GlassScriptPhysician profile
Peter Nguyen
NPI 1104576198
$1,577.11
in general payments reported to CMS, 2019-2025
7 companies · $773 in 2025
The $773 reported for 2025 was more than what 85% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $117 · 2024: $687 · 2025: $773.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,482 · Education: $94.66.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,482.45 |
| Education | $94.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $436.26 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $389.75 | 2024-2025 | Dupixent, Libtayo |
| Ucb, INC. | $211.31 | 2023-2024 | Bimzelx |
| Regeneron Pharmaceuticals, INC. | $149.61 | 2024 | Dupixent |
| Incyte Corporation | $139.46 | 2025 | Opzelura |
| Abbvie INC. | $125.74 | 2025 | |
| Sun Pharmaceutical Industries INC. | $124.98 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Nguyen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.